Skip to main content
Erschienen in: Current Bladder Dysfunction Reports 3/2019

28.06.2019 | Overactive Bladder (U Lee and S Adelstein, Section Editors)

Intraoperative Tips and Tricks for Successful Sacral Neuromodulation

verfasst von: Peter P. Ghamarian, Dena Moskowitz

Erschienen in: Current Bladder Dysfunction Reports | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

Sacral neuromodulation (SNM) is an effective, minimally invasive treatment for refractory overactive bladder, non-obstructive urinary retention, and fecal incontinence. Although the treatment is 80% successful, optimal outcomes over time are achieved only by applying precise surgical technique. In this review, we will present the surgical technique for optimal SNM documented in the literature, as well as provide tips for ideal placement based on the authors’ experience.

Recent Findings

The technique of SNM placement has greatly evolved over the last 10 years with the routine use of fluoroscopy as well as the introduction of the curved, tined lead. With these developments, surgeons have begun to pay more attention to motor thresholds needed to achieve anal bellows and toe flexion responses during staged lead implants. By achieving lower motor thresholds, ideally less than 2 mA, patients have a lower risk of future lead revision and may benefit from longer battery life and greater reprogramming options.

Summary

Ideal lead placement for SNM includes superior medial entry into the S3 foramen, with a lateral curvature of the distal lead to follow the S3 nerve root. Specific fluoroscopic findings, along with low motor thresholds for anal bellows and toe flexion, confirm ideal lead placement. Surgeons should make every effort to achieve the ideal lead. In patients with inadequate response to therapy, the lead can be checked on x-ray for ideal characteristics, and a revision should be considered if there is room for improvement.
Literatur
1.
Zurück zum Zitat Liberman D, Ehlert MJ, Siegel SW. Sacral neuromodulation in urological practice. Urology. 2017;99:14–22.CrossRefPubMed Liberman D, Ehlert MJ, Siegel SW. Sacral neuromodulation in urological practice. Urology. 2017;99:14–22.CrossRefPubMed
2.
Zurück zum Zitat Gormley EA, Lightner DJ, Faraday M, Vasavada SP. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline amendment. J Urol. 2015;193(5):1572–80.CrossRefPubMed Gormley EA, Lightner DJ, Faraday M, Vasavada SP. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline amendment. J Urol. 2015;193(5):1572–80.CrossRefPubMed
3.
Zurück zum Zitat Tanagho EA, Schmidt RA. Electrical stimulation in the clinical management of the neurogenic bladder. J Urol. 1988;140(6):1331–9.CrossRefPubMed Tanagho EA, Schmidt RA. Electrical stimulation in the clinical management of the neurogenic bladder. J Urol. 1988;140(6):1331–9.CrossRefPubMed
4.
Zurück zum Zitat Amend B, Matzel KE, Abrams P, de Groat WC, Sievert K-D. How does neuromodulation work. Neurourol Urodyn. 2011;30(5):762–5.CrossRefPubMed Amend B, Matzel KE, Abrams P, de Groat WC, Sievert K-D. How does neuromodulation work. Neurourol Urodyn. 2011;30(5):762–5.CrossRefPubMed
5.
Zurück zum Zitat Spinelli M, Giardiello G, Gerber M, Arduini A, van den Hombergh U, Malaguti S. New sacral neuromodulation lead for percutaneous implantation using local anesthesia: description and first experience. J Urol. 2003;170(5):1905–7.CrossRefPubMed Spinelli M, Giardiello G, Gerber M, Arduini A, van den Hombergh U, Malaguti S. New sacral neuromodulation lead for percutaneous implantation using local anesthesia: description and first experience. J Urol. 2003;170(5):1905–7.CrossRefPubMed
6.
Zurück zum Zitat • Goldman HB, Lloyd JC, Noblett KL, Carey MP, Castaño Botero JC, Gajewski JB, et al. International continence society best practice statement for use of sacral neuromodulation. Neurourol Urodyn. 2018;37(5):1823–48. These guidelines provide clinicians with appropriate, standardized use of SNM.CrossRefPubMed • Goldman HB, Lloyd JC, Noblett KL, Carey MP, Castaño Botero JC, Gajewski JB, et al. International continence society best practice statement for use of sacral neuromodulation. Neurourol Urodyn. 2018;37(5):1823–48. These guidelines provide clinicians with appropriate, standardized use of SNM.CrossRefPubMed
8.
Zurück zum Zitat • Borawski KM, Foster RT, Webster GD, Amundsen CL. Predicting implantation with a neuromodulator using two different test stimulation techniques: a prospective randomized study in urge incontinent women. Neurourol Urodyn. 2007;26(1):14–8. This randomized study highlighted the use of staged lead placement over peripheral nerve evaluation.CrossRefPubMed • Borawski KM, Foster RT, Webster GD, Amundsen CL. Predicting implantation with a neuromodulator using two different test stimulation techniques: a prospective randomized study in urge incontinent women. Neurourol Urodyn. 2007;26(1):14–8. This randomized study highlighted the use of staged lead placement over peripheral nerve evaluation.CrossRefPubMed
9.
Zurück zum Zitat Spinelli M, Weil E, Ostardo E, Del Popolo G, Ruiz-Cerdá JL, Kiss G, et al. New tined lead electrode in sacral neuromodulation: experience from a multicentre European study. World J Urol. 2005;23(3):225–9.CrossRefPubMed Spinelli M, Weil E, Ostardo E, Del Popolo G, Ruiz-Cerdá JL, Kiss G, et al. New tined lead electrode in sacral neuromodulation: experience from a multicentre European study. World J Urol. 2005;23(3):225–9.CrossRefPubMed
10.
Zurück zum Zitat Marcelissen T, Leong R, Serroyen J, van Kerrebroeck P, de Wachter S. Is the screening method of sacral neuromodulation a prognostic factor for long-term success? J Urol. 2011;185(2):583–7.CrossRefPubMed Marcelissen T, Leong R, Serroyen J, van Kerrebroeck P, de Wachter S. Is the screening method of sacral neuromodulation a prognostic factor for long-term success? J Urol. 2011;185(2):583–7.CrossRefPubMed
11.
Zurück zum Zitat •• Pizarro-Berdichevsky J, Gill BC, Clifton M, Okafor HT, Faris AE, Vasavada SP, et al. Motor response matters: optimizing lead placement improves sacral neuromodulation outcomes. J Urol. 2018;199(4):1032–6. This paper demonstrates the importance of precise lead placement in SNM outcomes as related to need for revision. CrossRefPubMed •• Pizarro-Berdichevsky J, Gill BC, Clifton M, Okafor HT, Faris AE, Vasavada SP, et al. Motor response matters: optimizing lead placement improves sacral neuromodulation outcomes. J Urol. 2018;199(4):1032–6. This paper demonstrates the importance of precise lead placement in SNM outcomes as related to need for revision. CrossRefPubMed
12.
Zurück zum Zitat Schmidt RA, Senn E, Tanagho EA. Functional evaluation of sacral nerve root integrity. Report of a technique. Urology. 1990;35(5):388–92.CrossRefPubMed Schmidt RA, Senn E, Tanagho EA. Functional evaluation of sacral nerve root integrity. Report of a technique. Urology. 1990;35(5):388–92.CrossRefPubMed
13.
Zurück zum Zitat Matzel KE, Chartier-Kastler E, Knowles CH, Lehur PA, Muñoz-Duyos A, Ratto C, et al. Sacral neuromodulation: standardized electrode placement technique. Neuromodulation J Int Neuromodulation Soc. 2017;20(8):816–24.CrossRef Matzel KE, Chartier-Kastler E, Knowles CH, Lehur PA, Muñoz-Duyos A, Ratto C, et al. Sacral neuromodulation: standardized electrode placement technique. Neuromodulation J Int Neuromodulation Soc. 2017;20(8):816–24.CrossRef
14.
Zurück zum Zitat Scheepens WA, Weil EH, van Koeveringe GA, Rohrmann D, Hedlund HE, Schurch B, et al. Buttock placement of the implantable pulse generator: a new implantation technique for sacral neuromodulation--a multicenter study. Eur Urol. 2001;40(4):434–8.CrossRefPubMed Scheepens WA, Weil EH, van Koeveringe GA, Rohrmann D, Hedlund HE, Schurch B, et al. Buttock placement of the implantable pulse generator: a new implantation technique for sacral neuromodulation--a multicenter study. Eur Urol. 2001;40(4):434–8.CrossRefPubMed
15.
Zurück zum Zitat Hijaz A, Vasavada SP, Daneshgari F, Frinjari H, Goldman H, Rackley R. Complications and troubleshooting of two-stage sacral neuromodulation therapy: a single-institution experience. Urology. 2006;68(3):533–7.CrossRefPubMed Hijaz A, Vasavada SP, Daneshgari F, Frinjari H, Goldman H, Rackley R. Complications and troubleshooting of two-stage sacral neuromodulation therapy: a single-institution experience. Urology. 2006;68(3):533–7.CrossRefPubMed
Metadaten
Titel
Intraoperative Tips and Tricks for Successful Sacral Neuromodulation
verfasst von
Peter P. Ghamarian
Dena Moskowitz
Publikationsdatum
28.06.2019
Verlag
Springer US
Erschienen in
Current Bladder Dysfunction Reports / Ausgabe 3/2019
Print ISSN: 1931-7212
Elektronische ISSN: 1931-7220
DOI
https://doi.org/10.1007/s11884-019-00522-x

Weitere Artikel der Ausgabe 3/2019

Current Bladder Dysfunction Reports 3/2019 Zur Ausgabe

Stress Incontinence and Prolapse (WS Reynolds, Section Editor)

Physical Activity and Stress Incontinence in Women

Post-Prostatectomy and Acquired Voiding Dysfunction (V Tse, Section Editor)

Rectourethral Fistula: Operative Technique and Outcomes

Post-Prostatectomy and Acquired Voiding Dysfunction (V Tse, Section Editor)

The Role of Estrogen Status in the Causation of Female Lower Urinary Tract and Pelvic Floor Dysfunction

Reconstructed Bladder Function & Dysfunction (M Kaufman, Section Editor)

Historical and Current Concepts Regarding Urodynamics in Multiple Sclerosis Patients

Reconstructed Bladder Function & Dysfunction (M Kaufman, Section Editor)

Urinary Retention Following Non-urologic Surgery

Overactive Bladder (U Lee and S Adelstein, Section Editors)

Patient Education for Overactive Bladder in the Digital Era

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

Stufenschema weist Prostatakarzinom zuverlässig nach

22.04.2024 Prostatakarzinom Nachrichten

Erst PSA-Test, dann Kallikrein-Score, schließlich MRT und Biopsie – ein vierstufiges Screening-Schema kann die Zahl der unnötigen Prostatabiopsien erheblich reduzieren: Die Hälfte der Männer, die in einer finnischen Studie eine Biopsie benötigten, hatte einen hochgradigen Tumor.

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

20.04.2024 EAU 2024 Kongressbericht

Beim chronischen Harnwegsinfekt bei Frauen wird bisher meist eine Antibiotikaprophylaxe eingesetzt. Angesichts der zunehmenden Antibiotikaresistenz erweist sich das Antiseptikum Methenamin-Hippurat als vielversprechende Alternative, so die Auswertung einer randomisierten kontrollierten Studie.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.